Causes of Siderosis in the Lungs

The causes of siderosis in the lungs can be traced to prolonged exposure to iron oxide dust or fumes. Also referred to as Welder’s lung, siderosis may affect workers in the welding, mining, iron rolling, metal sheet working and steel industries.

Occasional encounters with iron oxide are not enough to cause siderosis. Most patients with this form of pneumoconiosis have had consistent exposure to fumes and dust for an extended period of time, usually in the workplace. Siderosis causes small nodules to develop in the lower half of the lungs which are identified through a chest X-ray or CT scan. While siderosis alone doesn’t produce significant symptoms, it can increase the risk of other lung diseases that cause difficulty breathing, persistent coughing and an overall reduction in quality of life.

The Lung Institute offers an alternative treatment to siderosis and other chronic lung diseases in the form of autologous stem cell therapy. This innovative treatment may reduce lung inflammation, lessen severity of symptoms and help patients breathe easier. Stem cell therapy at the Lung Institute is relatively painless, has minimal risk of side effects and is performed on an outpatient basis over the course of two days. During the procedure, the patient’s own stem cells are used to help trigger the body’s natural healing mechanisms. The results are promising – more than 80 percent of Lung Institute patients report an improvement in quality of life following treatment.

While siderosis causes a negative change in your health, if you have been diagnosed with the disease you are not without hope. We encourage you to call us at (800) 729-3065 to speak with a member of our devoted team to learn how stem cell therapy at the Lung Institute may be beneficial for you.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.